Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore,...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Fan, Huang, Rongfeng, Lin, Dan, Wang, Yuying, Yang, Xiaohuang, Huang, Xiaoyun, Zheng, Biyun, Chen, Zhixin, Huang, Yuehong, Wang, Xiaozhong, Chen, Fenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942199/
https://www.ncbi.nlm.nih.gov/pubmed/33708180
http://dx.doi.org/10.3389/fmicb.2021.611323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942199/
https://www.ncbi.nlm.nih.gov/pubmed/33708180
http://dx.doi.org/10.3389/fmicb.2021.611323

Ejemplares similares